D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 47,045 391 World Ranking 10682 National Ranking 1010

Research.com Recognitions

Awards & Achievements

1992 - Fellow of the Royal Society of Edinburgh

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Cardiology

His primary areas of investigation include Internal medicine, Cardiology, Surgery, Myocardial infarction and Pravastatin. In his study, Obesity and Body mass index is inextricably linked to Diabetes mellitus, which falls within the broad field of Internal medicine. His research on Cardiology frequently connects to adjacent areas such as Prospective cohort study.

The Surgery study combines topics in areas such as Vitamin and B vitamins. His studies deal with areas such as Placebo and Blood pressure as well as Myocardial infarction. His study on Pravastatin also encompasses disciplines like

  • Randomized controlled trial which connect with Cardiac arrhythmia,
  • Heart Protection Study that intertwine with fields like Clinical endpoint, JUPITER trial and Lipid hypothesis.

His most cited work include:

  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (6962 citations)
  • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2750 citations)
  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (1677 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Cardiology, Electrocardiography, Myocardial infarction and QRS complex. The study of Internal medicine is intertwined with the study of Surgery in a number of ways. The Heart failure research Peter W. Macfarlane does as part of his general Cardiology study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.

His Myocardial infarction study often links to related topics such as Placebo. The various areas that Peter W. Macfarlane examines in his QRS complex study include Genetics and QT interval. His Prospective cohort study research focuses on Hazard ratio and how it relates to Stroke.

He most often published in these fields:

  • Internal medicine (59.70%)
  • Cardiology (50.50%)
  • Electrocardiography (23.38%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (59.70%)
  • Cardiology (50.50%)
  • Atrial fibrillation (8.96%)

In recent papers he was focusing on the following fields of study:

Peter W. Macfarlane mostly deals with Internal medicine, Cardiology, Atrial fibrillation, QRS complex and Genome-wide association study. His is doing research in Myocardial infarction, Disease, Prospective cohort study, Subclinical infection and Hazard ratio, both of which are found in Internal medicine. As a part of the same scientific study, Peter W. Macfarlane usually deals with the Myocardial infarction, concentrating on Placebo and frequently concerns with Anesthesia, Percutaneous coronary intervention and Randomized controlled trial.

Peter W. Macfarlane studies Cardiology, namely Electrocardiography. His Atrial fibrillation research includes themes of Stroke, Single lead, Risk of mortality and Heart failure. As a member of one scientific family, he mostly works in the field of QRS complex, focusing on QT interval and, on occasion, Pharmacogenomics and Epidemiology.

Between 2013 and 2021, his most popular works were:

  • Multi-Ethnic Genome-wide Association Study for Atrial Fibrillation (229 citations)
  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (219 citations)
  • The Early Repolarization Pattern : A Consensus Paper (201 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Myocardial infarction
  • Cardiology

His primary scientific interests are in Internal medicine, Cardiology, Genetics, Genome-wide association study and QRS complex. His Biomedical sciences research extends to Internal medicine, which is thematically connected. His Cardiology research is mostly focused on the topic Electrocardiography.

His Genome-wide association study study also includes

  • Genetic association which is related to area like Quantitative trait locus,
  • Atrial fibrillation that connect with fields like Confidence interval,
  • Cardiac conduction together with Case-control study, Medical genetics, Imputation and Heart block,
  • Expression quantitative trait loci that connect with fields like Cardiac muscle and Muscle hypertrophy,
  • Heart failure, which have a strong connection to Placebo, Randomized controlled trial, Stent, Percutaneous coronary intervention and Coronary occlusion. His QRS complex study combines topics from a wide range of disciplines, such as PR interval, QT interval and Traditional medicine. His Prospective cohort study study combines topics in areas such as Physical therapy and Pravastatin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

J Shepherd;S M Cobbe;I Ford;C G Isles.
The New England Journal of Medicine (1995)

12257 Citations

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen.
The Lancet (2002)

4373 Citations

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh.
The Lancet (2010)

2919 Citations

Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

Naveed Sattar;Allan Gaw;Olga Scherbakova;Ian Ford.
Circulation (2003)

2051 Citations

West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials

J Shepherd;SM Cobbe;AR Lorimer;JH McKillop.
The Lancet (1996)

1580 Citations

Pravastatin and the Development of Diabetes Mellitus Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

Dilys J. Freeman;John Norrie;Naveed Sattar;R. Dermot G. Neely.
Circulation (2001)

1249 Citations

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

Jill Belch;Angus MacCuish;Iain Campbell;Stuart Cobbe.
BMJ (2008)

1172 Citations

Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I: The Electrocardiogram and Its Technology A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology

Paul Kligfield;Leonard S. Gettes;James J. Bailey;Rory Childers.
Journal of the American College of Cardiology (2007)

806 Citations

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

CJ Packard;J Shepherd;SM Cobbe;Jane B Ford.
Circulation (1998)

757 Citations

Practice Standards for Electrocardiographic Monitoring in Hospital Settings An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young

Barbara J. Drew;Robert M. Califf;Marjorie Funk;Elizabeth S. Kaufman.
Circulation (2004)

739 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter W. Macfarlane

Naveed Sattar

Naveed Sattar

University of Glasgow

Publications: 223

J. Wouter Jukema

J. Wouter Jukema

Leiden University Medical Center

Publications: 140

Diana Kuh

Diana Kuh

University College London

Publications: 139

Ian Ford

Ian Ford

University of Glasgow

Publications: 127

Rudi G. J. Westendorp

Rudi G. J. Westendorp

University of Copenhagen

Publications: 123

Paul M. Ridker

Paul M. Ridker

Brigham and Women's Hospital

Publications: 117

Rebecca Hardy

Rebecca Hardy

University College London

Publications: 110

Patrick T. Ellinor

Patrick T. Ellinor

Harvard University

Publications: 99

Dimitri P. Mikhailidis

Dimitri P. Mikhailidis

University College London

Publications: 94

Anton J. M. de Craen

Anton J. M. de Craen

Leiden University Medical Center

Publications: 92

Stella Trompet

Stella Trompet

Leiden University Medical Center

Publications: 88

Chris J. Packard

Chris J. Packard

Glasgow Royal Infirmary

Publications: 85

Antonio M. Gotto

Antonio M. Gotto

Cornell University

Publications: 79

Scott M. Grundy

Scott M. Grundy

The University of Texas Southwestern Medical Center

Publications: 76

David J. Stott

David J. Stott

University of Glasgow

Publications: 75

Albert Hofman

Albert Hofman

Harvard University

Publications: 72

Trending Scientists

Oncel Tuzel

Oncel Tuzel

Apple (United States)

Soummya Kar

Soummya Kar

Carnegie Mellon University

Hyun Woo Lee

Hyun Woo Lee

LG Corporation (South Korea)

Ömer L. Gülder

Ömer L. Gülder

University of Toronto

Jhillu S. Yadav

Jhillu S. Yadav

Indian Institute of Chemical Technology

Bruno Gronenborn

Bruno Gronenborn

Centre national de la recherche scientifique, CNRS

Chengshu Wang

Chengshu Wang

Chinese Academy of Sciences

Johan Debevere

Johan Debevere

Ghent University

Ira Schwartz

Ira Schwartz

New York Medical College

John Lewin

John Lewin

Aberystwyth University

Kari E. J. Lehtinen

Kari E. J. Lehtinen

University of Eastern Finland

Kasper Kok

Kasper Kok

Wageningen University & Research

Maija Leinonen

Maija Leinonen

National Institutes of Health

Ethan Kross

Ethan Kross

University of Michigan–Ann Arbor

Brian G. Weinshenker

Brian G. Weinshenker

Mayo Clinic

David A. Williams

David A. Williams

University of Glasgow

Something went wrong. Please try again later.